Would you consider local therapy (e.g. XRT) in patients with mRCC with oligometastatic disease progression?
If current systemic treatment is otherwise controlling the disease and is well-tolerated, is there value to locally aggressive therapy in an attempt to preserve future treatment options?
1 Answer
Mednet Member
Medical Oncology · Cleveland Clinic
Answered on
This is a good question. The role of local therapy in mRCC should (in my opinion) be limited to 2 settings.
a) A patient with mRCC who is experiencing pain from a metastatic site.
b) A patient with an indolent disease course and overall low volume of metastatic disease in whom local therapy such as...
Join for free or sign in to see the full answer